These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 33536616)

  • 21. Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice.
    Shibata W; Kinoshita H; Hikiba Y; Sato T; Ishii Y; Sue S; Sugimori M; Suzuki N; Sakitani K; Ijichi H; Mori R; Endo I; Maeda S
    Sci Rep; 2018 Apr; 8(1):6150. PubMed ID: 29670173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.
    von Figura G; Fukuda A; Roy N; Liku ME; Morris Iv JP; Kim GE; Russ HA; Firpo MA; Mulvihill SJ; Dawson DW; Ferrer J; Mueller WF; Busch A; Hertel KJ; Hebrok M
    Nat Cell Biol; 2014 Mar; 16(3):255-67. PubMed ID: 24561622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
    Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
    Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis.
    Li ZY; Zhu SS; Chen XJ; Zhu J; Chen Q; Zhang YQ; Zhang CL; Guo TT; Zhang LM
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1018-1025. PubMed ID: 28942143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.
    Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I
    J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
    Wu CY; Carpenter ES; Takeuchi KK; Halbrook CJ; Peverley LV; Bien H; Hall JC; DelGiorno KE; Pal D; Song Y; Shi C; Lin RZ; Crawford HC
    Gastroenterology; 2014 Dec; 147(6):1405-16.e7. PubMed ID: 25311989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.
    Ray KC; Bell KM; Yan J; Gu G; Chung CH; Washington MK; Means AL
    PLoS One; 2011 Feb; 6(2):e16786. PubMed ID: 21311774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic reprogramming in Mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis.
    Mehmood R; Varga G; Mohanty SQ; Laing SW; Lu Y; Johnson CL; Kharitonenkov A; Pin CL
    PLoS One; 2014; 9(1):e84182. PubMed ID: 24465395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and manipulation of biliary metaplasia in pancreatic tumors.
    Delgiorno KE; Hall JC; Takeuchi KK; Pan FC; Halbrook CJ; Washington MK; Olive KP; Spence JR; Sipos B; Wright CV; Wells JM; Crawford HC
    Gastroenterology; 2014 Jan; 146(1):233-44.e5. PubMed ID: 23999170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
    Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.
    Zhang W; Nandakumar N; Shi Y; Manzano M; Smith A; Graham G; Gupta S; Vietsch EE; Laughlin SZ; Wadhwa M; Chetram M; Joshi M; Wang F; Kallakury B; Toretsky J; Wellstein A; Yi C
    Sci Signal; 2014 May; 7(324):ra42. PubMed ID: 24803537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
    Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
    Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SWI/SNF component
    Wang SC; Nassour I; Xiao S; Zhang S; Luo X; Lee J; Li L; Sun X; Nguyen LH; Chuang JC; Peng L; Daigle S; Shen J; Zhu H
    Gut; 2019 Jul; 68(7):1259-1270. PubMed ID: 30315093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
    Roy N; Malik S; Villanueva KE; Urano A; Lu X; Von Figura G; Seeley ES; Dawson DW; Collisson EA; Hebrok M
    Genes Dev; 2015 Mar; 29(6):658-71. PubMed ID: 25792600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.
    Saponara E; Visentin M; Baschieri F; Seleznik G; Martinelli P; Esposito I; Buschmann J; Chen R; Parrotta R; Borgeaud N; Bombardo M; Malagola E; Caflisch A; Farhan H; Graf R; Sonda S
    J Pathol; 2018 Nov; 246(3):352-365. PubMed ID: 30058725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.
    Dumartin L; Alrawashdeh W; Trabulo SM; Radon TP; Steiger K; Feakins RM; di Magliano MP; Heeschen C; Esposito I; Lemoine NR; Crnogorac-Jurcevic T
    Oncogene; 2017 Jun; 36(22):3094-3103. PubMed ID: 27941872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.
    Drosos Y; Neale G; Ye J; Paul L; Kuliyev E; Maitra A; Means AL; Washington MK; Rehg J; Finkelstein DB; Sosa-Pineda B
    Neoplasia; 2016 Mar; 18(3):172-84. PubMed ID: 26992918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.